Strategic Growth Leverage MicroAire's recent acquisition of NEOSYAD to position as a broader platform for adipose tissue engineering and related surgical devices, presenting cross-sell opportunities for integrated solutions and service packages.

Infection Control Highlight opportunities around single-use surgical systems and infection control enhancements, given the 2023 launch of a single-use carpal tunnel release system that reduces cross-contamination risk.

Global Expansion Target international operations and potential channel partnerships as the company grows, using its status as a global leader in power-assisted liposuction to expand distribution and training programs.

Mid-Market Growth With revenue in the mid-range and a headcount expansion history, propose scalable production, supply chain optimization, and maintenance services to support product development and volume growth.

Talent and Training Offer value through clinical training, education platforms, and customer success programs that align with continuous improvement and shared purpose to deepen customer relationships and adoption.